Product NDC: | 57664-113 |
Proprietary Name: | HydrOXYzine hydrochloride |
Non Proprietary Name: | HydrOXYzine hydrochloride |
Active Ingredient(s): | 25 mg/1 & nbsp; HydrOXYzine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-113 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040899 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090331 |
Package NDC: | 57664-113-83 |
Package Description: | 30 TABLET in 1 BOTTLE (57664-113-83) |
NDC Code | 57664-113-83 |
Proprietary Name | HydrOXYzine hydrochloride |
Package Description | 30 TABLET in 1 BOTTLE (57664-113-83) |
Product NDC | 57664-113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HydrOXYzine hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090331 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | HYDROXYZINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |